Unique ID issued by UMIN | UMIN000053393 |
---|---|
Receipt number | R000060927 |
Scientific Title | Study on the antihypertensive effect of supplementation |
Date of disclosure of the study information | 2024/01/19 |
Last modified on | 2024/01/19 09:27:11 |
Study on the antihypertensive effect of supplementation
Study on the antihypertensive effect of supplementation
Study on the antihypertensive effect of supplementation
Study on the antihypertensive effect of supplementation
Japan |
Healthy Adults
Not applicable |
Others
NO
Evaluate the antihypertensive effect of the supplement when taken by adult males aged 18 to 65 for 12 weeks.
Efficacy
Systolic and diastolic blood pressure at 4, 8, and 12 weeks after intake
Physical examination (weight/BMI), blood test (general biochemistry), general urinalysis
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Take 3 tablets of the supplement with water before dinner every day for 12 weeks.
Take 3 tablets of the placebo food with water before dinner every day for 12 weeks.
18 | years-old | <= |
65 | years-old | > |
Male
1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Japanese persons who are 18 years old or more and under 65 years old
1.Persons who have chronic illness, receiving medication, have a serious disease history
2.Persons who have been diagnosed with hypertension by a doctor
3.Persons who have allergies to the test food
4.Persons who usually take a large amount of test food
5.Persons who usually take medicine, specified health food, healthy food and supplements that may affect blood pressure and salt absorption/excretion
6.Persons who have a drinking habit (drinking more than 1 go of sake per drinking day on 3 or more days a week)
7.Systolic blood pressure of 160 mmHg or more or diastolic blood pressure of 100 mmHg or more
8.BMI less than 18.5 or greater than 30
9.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
10.Persons who were judged as inappropriate for study participants by the principal investigator
60
1st name | Takamasa |
Middle name | |
Last name | Masuda |
Healthcare Systems Co., Ltd.
Clinical Research Department
105-0004
Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN
03-6809-2722
masudat@hc-sys.jp
1st name | Takamasa |
Middle name | |
Last name | Masuda |
Healthcare Systems Co., Ltd.
Clinical Research Department
105-0004
Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN
03-6809-2722
masudat@hc-sys.jp
Healthcare Systems Co., Ltd.
TOYMEDICAL Ltd.
Profit organization
The Ethics Committee of Healthcare Systems Co., Ltd.
1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN
03-6809-2722
soumu@hc-sys.jp
NO
2024 | Year | 01 | Month | 19 | Day |
Unpublished
Preinitiation
2024 | Year | 01 | Month | 19 | Day |
2024 | Year | 01 | Month | 23 | Day |
2024 | Year | 04 | Month | 30 | Day |
2024 | Year | 01 | Month | 19 | Day |
2024 | Year | 01 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060927
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |